Article
Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Hematology/oncology and stem cell therapy - 1 Jun 2016
Rujito Lantip, Basalamah Muhammad, Siswandari Wahyu, Setyono Joko, Wulandari Gondo, Mulatsih Sri, Sofro Abdul Salam M, Sadewa Ahmad Hamim, Sutaryo Sutaryo
Abstract excerpt
OBJECTIVE/BACKGROUND: Thalassemia is a monogenic hematologic disease that has the highest prevalence globally. In addition, there is complexity of the genetic background associated with a variety of phenotypes presented among patients. Genetic heterogeneity related to fetal hemoglobin (HbF) production has been reported as an influencing phenotypic factor of β-thalassemia (β-thal). Therefore, this study aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
